The European molecular diagnostics market is expected to grow decisively with the full integration of precision medicine in routine clinical practice․ Increasingly complex diseases‚ an ageing population‚ and increasing precision medicine breakthroughs in nucleic acid-based testing are redefining hospitals‚ laboratories and public health agencies' approaches to disease...